Cargando…

Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta‐analysis of randomized controlled trials

AIM: Pharmacological treatments recommended for bipolar depression are inconsistent across guidelines. We compared the efficacy and safety of antipsychotics and mood stabilizers for bipolar depression. METHODS: A systemic review and meta‐analysis of randomized controlled trials comparing antipsychot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogasawara, Masaya, Takeshima, Masahiro, Esaki, Yuichi, Kaneko, Yoshiyuki, Utsumi, Tomohiro, Aoki, Yumi, Watanabe, Norio, Suzuki, Masahiro, Takaesu, Yoshikazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773747/ https://www.ncbi.nlm.nih.gov/pubmed/35858678 http://dx.doi.org/10.1002/npr2.12283

Ejemplares similares

Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta‐analysis
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials
por: Maruki, Taku, et al.
Publicado: (2022)

Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics
por: Aoki, Yumi, et al.
Publicado: (2021)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

PS34. Effect of Quetiapine XR on Circadian Rhythm Compared with Lithium in Patients with Bipolar Depression
por: Choi, Jae-Won, et al.
Publicado: (2016)

Treatment strategy for insomnia disorder: Japanese expert consensus
por: Takaesu, Yoshikazu, et al.
Publicado: (2023)

A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation: A Cross-Sectional Survey in Japan
por: Aoki, Yumi, et al.
Publicado: (2023)

The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole
por: Missio, Giovani, et al.
Publicado: (2013)

Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database
por: Takeshima, Masahiro, et al.
Publicado: (2022)

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Gedge, Laura, et al.
Publicado: (2010)

Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
por: Murasaki, Mitsukuni, et al.
Publicado: (2018)

Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
por: Takeshima, Masahiro, et al.
Publicado: (2022)

Physicians’ attitudes toward hypnotics for insomnia: A questionnaire-based study
por: Takeshima, Masahiro, et al.
Publicado: (2023)

Quetiapine for acute bipolar depression: a systematic review and meta-analysis
por: Suttajit, Sirijit, et al.
Publicado: (2014)

Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
por: Aoki, Yumi, et al.
Publicado: (2023)

Comparison of the effect of lithium plus quetiapine with lithium plus risperidone in children and adolescents with bipolar I disorder: a randomized clinical trial
por: Habibi, Nastaran, et al.
Publicado: (2017)

Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression
por: Kanba, Shigenobu, et al.
Publicado: (2019)

Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder
por: Wrobel, Anna L., et al.
Publicado: (2022)

Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes
por: Hardoy, Maria Carolina, et al.
Publicado: (2007)

Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
por: Simon, Judit, et al.
Publicado: (2018)

Role of extended release quetiapine in the management of bipolar disorders
por: Al Jurdi, Rayan K, et al.
Publicado: (2010)

Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment
por: McKeown, Lucas, et al.
Publicado: (2022)

Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
por: Young, Allan H, et al.
Publicado: (2013)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

Efficacy and Safety of Quetiapine for Pediatric Bipolar Depression: A Systematic Review of Randomized Clinical Trials
por: Srinivas, Sushma, et al.
Publicado: (2020)

Is aripiprazole similar to quetiapine for treatment of bipolar depression? Results from meta-analysis of Chinese data
por: Tao, Hejian, et al.
Publicado: (2022)

Changes in the brain structural connectome after a prospective randomized clinical trial of lithium and quetiapine treatment in youth with bipolar disorder
por: Lei, Du, et al.
Publicado: (2021)

Implementation of a shared decision-making training program for clinicians based on the major depressive disorder guidelines in Japan: A multi-center cluster randomized trial
por: Takaesu, Yoshikazu, et al.
Publicado: (2022)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili, Nizar
Publicado: (2012)

Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study
por: Diao, Xiangyuan, et al.
Publicado: (2022)

A pilot trial of quetiapine, lithium, or placebo added to divalproex sodium for hypomanic or manic episodes in ambulatory adults with bipolar I disorder
por: Cosgrove, Victoria E., et al.
Publicado: (2022)

Management of unspecified anxiety disorder: Expert consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2023)

Severe fatigue due to valproate-induced hypothyroidism in a case of bipolar disorder
por: Kanamori, Tadashi, et al.
Publicado: (2020)

Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations: A Case Series of Bipolar Type 2 Patients
por: Rovera, C., et al.
Publicado: (2017)

Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode
por: Yoshizawa, Kazuhisa, et al.
Publicado: (2021)

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
por: Mundo, Emanuela, et al.
Publicado: (2006)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Gajwani, Prashant, et al.
Publicado: (2007)

Aggravation of Hypertriglyceridemia and Acute Pancreatitis in a Bipolar Patient Treated with Quetiapine
por: Liou, Li-Syue, et al.
Publicado: (2014)

Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update
por: Muneer, Ather
Publicado: (2015)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5bjjrkukej5b7lct4dredn0asu